Position in VRTX
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$2,467,580
+$62,506 QoQ
Shares Held
5,526
+4.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.5428881650380022.ToString("F0")%
Shared 0.ToString("F0")%
None 99.45711183496199.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SIGNATUREFD, LLC holds $11,812,434 across 171 Biotechnology names. VRTX ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,526 | $2,467,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,995 | $1,541,416 | |
| 3 | ARGX |
Argenx SE
|
1,813 | $1,323,943 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,047 | $677,290 | |
| 5 | GMAB |
Genmab A/S
|
15,780 | $423,377 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
7,120 | $413,743 | |
| 7 | INCY |
Incyte Corp
|
3,385 | $318,596 | |
| 8 | EXEL |
Exelixis, Inc.
|
6,054 | $259,656 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,467,580 | 5,526 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,405,074 | 5,305 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,998,538 | 5,103 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,359,560 | 5,300 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,765,898 | 5,705 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,033,232 | 5,049 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,394,696 | 5,149 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,387,659 | 5,094 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,208,764 | 5,284 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,992,133 | 4,896 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,546,747 | 4,448 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,456,907 | 4,140 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,182,772 | 3,754 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,005,531 | 3,482 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $971,985 | 3,357 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $836,634 | 2,969 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $688,177 | 2,637 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $506,617 | 2,307 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $304,009 | 1,676 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $667,798 | 3,312 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $711,071 | 3,309 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $719,655 | 3,045 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $544,512 | 2,001 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $591,361 | 2,037 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $390,000 | 1,639 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||